Galapagos NV, which has service and drug development divisions, has appointed David Smith to the newly created position of chief executive officer of its service division. This division comprises the companies BioFocus, Argenta and Fidelta. Mr Smith will report to Onno van de Stolpe, the Galapagos chief executive, and join the group’s executive committee.
Mr Smith was previously finance director of Cambridge University Hospitals in the UK. Before that, he was chief financial officer of Galapagos.
Copyright 2013 Evernow Publishing Ltd.